
The funding will be for a GLP-1 receptor agonist clinical programme for weight loss

The new site will expand research capabilities across immunology, neuroscience and oncology

The use of Rinvoq in non-segmental vitiligo is under regulatory review by the US FDA

NSV is a chronic autoimmune disease where the immune system attacks melanin-producing cells, leading to a loss of pigment

Around 33,000 people in the UK are currently living with multiple myeloma, an incurable type of blood cancer

There are currently no approved human vaccines for Lyme disease

Tom Cavanaugh has been appointed as Executive Vice President, Worldwide Chairman Innovative Medicine

Rinvoq is the first and only systemic medication approved in the EU for NSV

Litfulo delivered significant, clinically meaningful improvements for both face and body

The resolution comes after plaintiffs were unable to prove that J&J’s talc products caused their ovarian cancer

The phase 3 trial showed greater than 50% improvement in radiographic progression-free survival

Globally, an estimated 64 million people have psoriasis, with about 80-90% of those having plaque psoriasis